TGTX
TG Therapeutics Inc
-19.05%
$18.43 - $14.92
Feb 7th 2023 - Mar 21st 2023
Feb, 18, 2023
Remember that we are ultimately at the beginning o... See more
Jan, 29, 2023
$TGTX makes a lot of sense to do a 300M offering here imo
BIDU
Baidu Inc - ADR
-2.42%
$152.34 - $148.66
Feb 8th 2023 - Mar 22nd 2023
Mar, 16, 2023
Saxo Markets said that the general rhetoric delive... See more
Jan, 24, 2023
$BABA $BIDU 300$ 500$ According to The Hill, an A... See more
BOXD
Boxed Inc
-77.49%
$0.53 - $0.12
Feb 7th 2023 - Mar 21st 2023
Jan, 20, 2023
It will help the buyout pricing room go fking do it!! !
Jan, 10, 2023
Based on some buyout pricing model and Kroger offe... See more
Feb, 18, 2023
Remember that we are ultimately at the beginning of commercialization and quite possible the safest spot to be with the current facts on our superior Briumvi treatment and best pricing for market share penetration.
Jan, 29, 2023
$TGTX makes a lot of sense to do a 300M offering here imo
Jan, 1, 2023
What stuck out was the combined value proposition: efficacy, safety, convenience, marketability, pricing, etc.
Dec, 30, 2022
The analyst comments "TGTX stock is up >15% (versus +4% for XBI) driven by: 1) positive comments on pricing: we think list price is rational with some discount vs. Ocrevus to lower cost burden and get broad access,
Dec, 29, 2022
$TGTX FDA approval for Billion dollar MS drug — great things in store 2023 $DRMA just officially dropped offering, makes me feel company has something good up it’s sleeve.
Dec, 29, 2022
The analyst comments "TGTX stock is up >15% (versus +4% for XBI) driven by: 1) positive comments on pricing: we think list price is rational with some discount vs. Ocrevus to lower cost burden and get broad access,
Dec, 29, 2022
Amazing positive news from the TGTX 20221229 conference call, FDA approved, 🚨🔥🚨 Ublituximab Briumvi: 1) No need for additional funds, no offering, no need for capital raise, because 220 million in cash reserves expected to last until mid 2024.
Mar, 16, 2023
Saxo Markets said that the general rhetoric delivered by the new premier is pro-growth and market-friendly, offering strong tailwind to equities.
Jan, 24, 2023
$BABA $BIDU 300$ 500$ According to The Hill, an American newspaper and digital media company, China could bounce back both stronger and sooner than expected, offering a rare source of optimism for the U.S. economy amid rising recession fears.
Nov, 14, 2022
This is going up to $20 No need or any more stock offering Today is the best day and the lowest price you will ever buy TBLT for.
Nov, 5, 2022
The company’s cloud business is one of the largest and fastest growing in China and is differentiated by its AI solutions and higher-value PaaS/SaaS offerings.
Oct, 12, 2022
but underlying goods prices were unchanged for the first time in nearly 2-1/2 years, offering some hope in the battle against inflation.